The Science of Longevity: What Research Tells Us About Living Better, Longer

What Is Biological Aging?

Chronological age — the number of years you have been alive — is only one measure of aging. Biological age reflects the actual functional state of your cells, tissues, and organs. Two people of the same chronological age can have dramatically different biological ages depending on genetics, lifestyle, and nutrition.

The field of geroscience studies the biological mechanisms of aging with the goal of extending healthspan — the period of life spent in good health — rather than simply lifespan. Key discoveries over the past two decades have identified several hallmarks of aging at the cellular level.

The Hallmarks of Aging

In a landmark 2013 paper published in Cell, López-Otín and colleagues identified nine hallmarks of aging — molecular and cellular changes that accumulate over time and drive the aging process.

Critically, these hallmarks are interconnected. Mitochondrial dysfunction, for example, accelerates genomic instability and cellular senescence. Addressing one hallmark often has downstream benefits across others.

• Genomic instability — accumulation of DNA damage
• Telomere attrition — shortening of protective chromosome caps
• Epigenetic alterations — changes in gene expression patterns
• Loss of proteostasis — decline in protein quality control
• Deregulated nutrient sensing — impaired metabolic signalling
• Mitochondrial dysfunction — reduced cellular energy production
• Cellular senescence — accumulation of non-dividing "zombie" cells
• Stem cell exhaustion — reduced regenerative capacity
• Altered intercellular communication — chronic low-grade inflammation

NAD⁺ Decline: A Central Driver

One of the most well-documented molecular changes in aging is the decline of NAD⁺ (nicotinamide adenine dinucleotide) — a coenzyme found in every living cell. NAD⁺ levels fall by approximately 50% between ages 40 and 60, and this decline is now understood to contribute directly to multiple hallmarks of aging including mitochondrial dysfunction, genomic instability, and deregulated nutrient sensing.

NMN (nicotinamide mononucleotide) is the most direct and clinically validated precursor to NAD⁺. Multiple human randomised controlled trials have confirmed that oral NMN supplementation safely and effectively raises blood NAD⁺ levels in middle-aged and older adults.

Oxidative Stress and Cellular Protection

Alongside NAD⁺ decline, oxidative stress — the accumulation of reactive oxygen species (ROS) that damage cellular structures — is a key driver of biological aging. Mitochondria are both the primary source and primary target of ROS, creating a damaging feedback loop as we age.

L-Ergothioneine (ERGO) is a naturally occurring amino acid with exceptional antioxidant properties. Unlike most antioxidants, ERGO is actively transported into cells via a dedicated transporter (SLC22A4) and concentrates specifically in mitochondria and nuclei — the cellular structures most vulnerable to oxidative damage. This targeted accumulation makes it uniquely effective at protecting the machinery of cellular energy production.

The Synergy of NMN and Ergothioneine

The combination of NMN and L-Ergothioneine is scientifically compelling because their mechanisms are complementary. NMN fuels NAD⁺ production — restoring the cellular energy currency that declines with age. Ergothioneine protects the mitochondrial machinery that uses NAD⁺, reducing the oxidative damage that would otherwise undermine the benefits of restored NAD⁺ levels.

This is the scientific rationale behind ErgoNMN™ — a formula that addresses two interconnected hallmarks of aging in a single, precisely dosed supplement.